US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the ADME-Tox Screening Systems market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the ADME-Tox Screening Systems market." ADME-Tox screening is system is an integrated workstation for describing of the absorption, distribution, metabolism, and excretion properties of drug molecules. ADME-Tox screening system includes biochemical assay tester which measures the physicochemical properties of a drug molecule. This system also supports the permeability assays testing which measures the drug affinity toward metabolic enzyme. ADME-Tox screening system is enabled with highly integrated software which has an inbuilt protocol for the sample testing. The protocol feed in the software can be edited as per the customized need of sample testing. ADME-Tox screening system is connected to the multi-mode reader which allows runs the wide range of protocol on primary and secondary screen. This system provide accurate toxicity test for the drug development and biopharmaceutical production. The increasing focus of drug manufacturer to reduce the development cost of drug with least toxicological issue is the major factor driving the growth of ADME-Tox screening system market. Beside the ADME-Toxicological testing increases the potential of drug which increases the efficiency of the drug to target the desired tissue. Moreover, increasing demand for specialized drug due to rising prevalence of various chronic diseases will also upsurge the growth of AME-Tox screening system market. High installation and maintenance cost of this system will hamper the growth of this market. Additionally, lack of skilled professional to operate this system will also responsible for the sluggish growth of this market. North America is expected to dominate the ADME-Tox screening system market due to the presence of a large number of biopharmaceutical companies in this region. Europe and Asia-Pacific will follow the North America for the ADME-Tox screening system market. In Asia-Pacific India and China are expected to be fastest growing market over the forecast period owing increased focus of leading biopharmaceutical manufacturer to expand their subsidiaries in these countries. The global ADME-Tox Screening Systems market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on ADME-Tox Screening Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall ADME-Tox Screening Systems market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Hudson Robotics Agilent Tsechnologies ADMEcell BioreclamationIVT Beckman Counter Cerep ... Segment by Regions North America Europe China Japan Segment by Type Instruments Assay system Software Segment by Application Discovery and Development Biopharmaceutical Production Drug Screening Tissue Engineering Others
Table of Contents Executive Summary 1 ADME-Tox Screening Systems Market Overview 1.1 Product Overview and Scope of ADME-Tox Screening Systems 1.2 ADME-Tox Screening Systems Segment by Type 1.2.1 Global ADME-Tox Screening Systems Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Instruments 1.2.3 Assay system 1.2.4 Software 1.3 ADME-Tox Screening Systems Segment by Application 1.3.1 ADME-Tox Screening Systems Consumption Comparison by Application (2014-2025) 1.3.2 Discovery and Development 1.3.3 Biopharmaceutical Production 1.3.4 Drug Screening 1.3.5 Tissue Engineering 1.3.6 Others 1.4 Global ADME-Tox Screening Systems Market by Region 1.4.1 Global ADME-Tox Screening Systems Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global ADME-Tox Screening Systems Market Size 1.5.1 Global ADME-Tox Screening Systems Revenue (2014-2025) 1.5.2 Global ADME-Tox Screening Systems Production (2014-2025) 2 Global ADME-Tox Screening Systems Market Competition by Manufacturers 2.1 Global ADME-Tox Screening Systems Production Market Share by Manufacturers (2014-2019) 2.2 Global ADME-Tox Screening Systems Revenue Share by Manufacturers (2014-2019) 2.3 Global ADME-Tox Screening Systems Average Price by Manufacturers (2014-2019) 2.4 Manufacturers ADME-Tox Screening Systems Production Sites, Area Served, Product Types 2.5 ADME-Tox Screening Systems Market Competitive Situation and Trends 2.5.1 ADME-Tox Screening Systems Market Concentration Rate 2.5.2 ADME-Tox Screening Systems Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global ADME-Tox Screening Systems Production Market Share by Regions 3.1 Global ADME-Tox Screening Systems Production Market Share by Regions 3.2 Global ADME-Tox Screening Systems Revenue Market Share by Regions (2014-2019) 3.3 Global ADME-Tox Screening Systems Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America ADME-Tox Screening ... | read more...